Lung Cancer — Time to Move on from Chemotherapy
- 10 January 2002
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 346 (2) , 126-128
- https://doi.org/10.1056/nejm200201103460211
Abstract
In 2001 lung cancer caused more than 1 million deaths worldwide. Despite the well-recognized link between tobacco use and the development of lung cancer, the number of new cases continues to rise, especially among women. In girls and women 15 to 64 years of age, lung cancer is now the leading cause of death from cancer, and this disease remains the most common cause of death from cancer in men.1 During the past 20 years, numerous efforts have been made to reduce the death rate among patients with lung cancer. Treatment involves surgery, radiation therapy, combination chemotherapy, or a combined . . .Keywords
This publication has 14 references indexed in Scilit:
- Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung CancerNew England Journal of Medicine, 2002
- Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group TrialJournal of Clinical Oncology, 2001
- Cancer Statistics, 2001CA: A Cancer Journal for Clinicians, 2001
- Lung cancer screeningCancer, 2000
- Early Lung Cancer Action Project: overall design and findings from baseline screeningThe Lancet, 1999
- Twenty Years of Phase III Trials for Patients With Extensive-Stage Small-Cell Lung Cancer: Perceptible ProgressJournal of Clinical Oncology, 1999
- Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.Journal of Clinical Oncology, 1995
- Reducing tobacco consumption in California. Development of a statewide anti-tobacco use campaignJAMA, 1990
- A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.Journal of Clinical Oncology, 1986